Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchONCOLOGY
Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchNEUROLOGY
Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
- Patient: Mr Jim Willison, Sheffield, OH, USA
- Physical Therapist: Dr Lisa Fukuzato, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchNEUROLOGY
Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchNEUROLOGY
Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Neurologist: Dr James Wymer, Gainesville, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchRESPIRATORY
Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
- Patient: Mr Jim Willison, Sheffield, OH, USA
- Physical Therapist: Dr Lisa Fukuzato, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchRESPIRATORY
Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchNEUROLOGY
Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Neurologist: Dr James Wymer, Gainesville, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies//?_ga=2.65262702.1175448380.1654530922-407959475.1653925964
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies/?_ga=2.29473663.1151443503.1654521477-1202917360.1651662103
Tuesday Mar 15, 2022
Tuesday Mar 15, 2022
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives share their expert insights on the impact of cognitive dysfunction in relapsing MS, and how to best assess and manage the associated cognitive symptoms.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
- Neuropsychologist: Prof. Dawn Langdon, UK
- Advanced practice clinician: Ms Amy Perrin Ross, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms